Stock screener

INCY

Conviction 83HealthcareScan · Mon, Jul 20, 2026
INCY$115.67-1.35%
ResistanceSupportVol 14Insider sellCongress buyCongress sell
63 bars
Vol MA14 1.73M
Apr 20May 6May 26Jun 11Jul 1Jul 20
INCYTE CORPSERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCHwww.incyte.com ↗
Price115.67
Change-1.35%
Gap-0.16%
Rel volume1.16×
Avg volume1.86M
Avg $ vol211.42M
SMA 20113.82
SMA 50104.98
SMA 20099.69
Price vs 50+10.18%
Price vs 200+16.03%
MA stackbullish
50/200 cross—
Supertrendup · 107.40
RSI (14)60
MACD hist-0.40
MACD crossbear · 4d
Stoch %K / %D57 / 69
ADX (14)29
+DI / −DI27 / 18
RSI divergenceBearish
MACD divergenceBearish
ATR %+3.07%
ADR %2.96%
52w high118.52
52w low67.38
From 52w high-2.40%
Above 52w low+71.67%
New 52w highNo
SqueezeOff
Bollinger width14.91%
%B0.61
Donchian pos80.16%
Donchian high119.60
Donchian low99.79
AVWAP (52w high)117.04
vs AVWAP high-1.17%
AVWAP (52w low)96.34
vs AVWAP low+20.06%
OBV trendUp
Chaikin MF (20)0.14
Today vs 20d1.16×
Avg vol (14d)1.73M
Avg vol (20d)1.86M
Avg $ vol (20d)211.42M
Market cap23.11B
RS 3m (vs SPY)+17.07%
RS 6m (vs SPY)+3.00%
RS line new highYes
Trend template8/8
Technical rank82.2
1 week+1.26%
1 month+16.85%
3 months+18.25%
6 months+9.91%
1 year+67.78%
YTD+14.05%
P/E17.96
P/B4.11
P/S4.49
P/FCF16.93
EPS6.41
Div yield—
ROE22.88%
ROA17.53%
Debt/Eq0.18
Current3.68
EV/EBITDA12.84
Gross margin—
Net margin25.03%
Rev growth21.22%
EPS growth3844.96%
Price target116.41
Target upside0.64%
Analyst ratingHold
Institutional113.66%
Ent. value20.65B
Revenue1.27B
Net income303.33M
Gross profit—
Free cash flow1.36B
IndustrySERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
ExchangeNasdaq
Shares out199.78M
Employees2.84K
ListedWed, Nov 3, 1993
Free float166.24M
Float %83.5%
Short interest10.58M
Days to cover4.8d
Short volume55.1%
Squeeze score49 / 100
Next earningsTue, Jul 28, 2026 · pre-mkt (8d)
EPS forecast$1.61 · 7 est
Last EPS vs est$1.55 vs $1.14
Last surprise+36.0% beat
Setup gradeA
Conviction83 / 100
Pattern quality—
Tech rank82.2 / 100
Group rank23 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance118.83
Support94.14
Days since event—
Candle confirm—
News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in INCY · 1 recent

All disclosures →
MemberSideAmount
Rob Bresnahan
Rob Bresnahan
house · PA · traded 2025-05-15
Sell$1K–$15K

Insider activity

SEC Form 4 transactions in INCY · 10 sells

InsiderSideShares
Stein Steven H
CMO & Head of Late-Stage Dev. · Common Stock · 2026-07-15
Tax3.09K
Stein Steven H
CMO & Head of Late-Stage Dev. · Common Stock · 2026-07-15
Sell28.24K
CAGNONI PABLO J
President, Global Head of R&D · Common Stock · 2026-07-15
Tax4.95K
Issa Mohamed Khairie
EVP, Head of U.S. Commercial · Common Stock · 2026-07-15
Tax1.1K
Tray Thomas
Principal Accounting Officer · Common Stock · 2026-07-15
Tax1.1K
Mayes Patrick A
EVP & Chief Scientific Officer · Common Stock · 2026-07-15
Tax1.51K
CAGNONI PABLO J
President, Global Head of R&D · Common Stock · 2026-07-14
Tax17.97K
Tray Thomas
Principal Accounting Officer · Common Stock · 2026-07-14
Tax692
Mayes Patrick A
EVP & Chief Scientific Officer · Common Stock · 2026-07-14
Tax437
Stein Steven H
CMO & Head of Late-Stage Dev. · Common Stock · 2026-07-14
Tax21.83K

SEC filings

EDGAR filings in INCY · 8 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.